Skip To Main Content
F. Barbero on Muck Rack

F. Barbero

As seen in: Journal of Translational Medicine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with F.

Contact F., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Identification of prognostic liquid biopsy biomarkers in patients with cutaneous squamous cell carcinoma treated with cemiplimab - Journal of Translational Medicine

|
By Integrated Diagnostics, Genetica Oncologica, U.O. Epidemiologia Clinica, S. Hernández Santamaría, A. Bosio, A. Rosa, P. Ghiorzo, I. Vanni, E. Allavena, F. Barbero, A. Boutros, V. Fontana, F. Spagnolo, E. T. Tanda
| Journal of Translational Medicine Verified
Cemiplimab was administered to patients considered unsuitable for curative surgery or radiotherapy, as determined by a multidisciplinary team discussion. Cemiplimab was administered intravenously (IV) at a dose of 350 mg flat dose every 3 weeks. The clinical response was assessed radiologically according to the RECIST 1.1 criteria [23] or clinically according to the WHO criteria [24].
Open in Who Shared Issue with article?
See all 1 articles